Federal Health Minister Syed Mustafa Kamal has pledged decisive reforms in Pakistan’s healthcare system, with a focus on expanding access, improving quality, and modernising regulatory processes to better serve the nation.

Chairing a high-level session at the Drug Regulatory Authority of Pakistan (DRAP), the Minister emphasized the government’s unwavering commitment to overhauling the health sector through technology, transparency, and efficiency. The meeting was also attended by Federal Health Secretary Syed Waqar ul Hassan, senior health officials, and DRAP’s CEO.

A key agenda item was the digitisation of the regulatory framework for medical devices, a move aimed at streamlining approvals and strengthening oversight. “We are shifting to an online registration and licensing system for medical devices—this is a major step toward modernising Pakistan’s health regulation,” Kamal announced.

Reiterating the government’s stance, he stressed, “We will never compromise on the health of our citizens or the standards of medicines. Quality and safety remain our top priorities.”

The Minister also underlined the economic potential of the pharmaceutical and medical device industries, stating that comprehensive reforms and digital transformation will unlock export opportunities and drive growth.

As part of a broader vision, Kamal said efforts are underway to transform DRAP into a transparent, responsive, and citizen-focused body that can ensure timely access to safe medicines across the country.

An integrated strategy has already been developed to promote pharmaceutical exports, aiming to strengthen Pakistan’s footprint in international markets while meeting domestic healthcare needs.

The meeting ended with a renewed resolve to accelerate reforms and reinforce Pakistan’s healthcare infrastructure through innovation and institutional strengthening.